Our Pipeline

Translating cutting-edge science into breakthrough therapeutics

Pipeline

Development Pipeline

Discovery

Preclinical Validation

Lead Optimization

Ind-enabling

Phase I

Phase II/III

PST010

Oncology

Stage: Lead Optimization

Target Undisclosed (PPI)

In-house

collaboration

Protein-protein interaction

Solid tumors

New mode of action

PST020

Infectious Diseases

Stage: Lead Optimization

Target Undisclosed (PPI)

In-house

collaboration

Emerging infectious diseases

Bacterial pathogenesis

PST030

Oncology

Stage: Discovery

Target Undisclosed (PPI)

In-house

collaboration

Cell growth and proliferation

New mode of action

Solid tumors

PST040

CNS

Stage: Discovery

Target Undisclosed (PPI)

In-house

collaboration

Neurodegeneration

Neuropathology

Signal transduction

PIPELINE | ONCOLOGY

Aiming to improve survival rates for the most lethal tumor forms, we primarily strive to develop novel and universal cancer therapies.

PIPELINE | Beyond Oncology

While we focus on oncology in-house, we aim to fully utilize our platform’s potential and build a diversified portfolio of assets with strong partners on our side.

Cardiovascular Diseases

Infectious Diseases

Neurodegenerative Disease

Further Diseases

Get in touch